GLP-1 Access by State

Calculator

State lookup

Choose any state or DC and get one card: the medical board licence lookup and board of pharmacy link (each checked on a recorded date), Interstate Medical Licensure Compact membership, the telehealth in-person exam rule for non-controlled drugs with the statute we read or an honest 'check with the board', the Medicaid fee-for-service position on anti-obesity GLP-1s with its source and date, and compounding notes where a state source exists. Compare two states side by side and copy everything as plain text. Nothing is scored or recommended.

By FormBlends editorial teamAssumptions checked September 4, 2026 Runs in your browser; nothing is sent to a server

What it computes

Pick a state, see its licence lookups, compact status, telehealth rule and Medicaid position, and copy the links.

Never pre-fills a dose

Pick a state

Use the state where you will be located during the telehealth visit; that is the state whose rules apply.

Useful if you split time between two states or are moving.

Choose a state to see its prescriber licence lookup, board of pharmacy, compact status, telehealth prescribing rule for non-controlled drugs, Medicaid position on anti-obesity GLP-1s, and any compounding notes, each with its source and check date. 51 jurisdictions are loaded.
Formula
card(state) = licence lookup (state medical board, checked by request on the date shown)
            + board of pharmacy (Compounding Explained verified list, shared data file)
            + IMLC membership (Commission participating-states map, imlcc.com)
            + telehealth rule (statute or board rule text read on the date shown, else 'check with the board')
            + Medicaid status (KFF January 2026 map, replaced by a state agency source where one exists)
            + compounding notes (state primary sources only) + the federal FDA baseline
counts: 47 of 51 telehealth rules verified; 37 lookups checked live, 14 browser-only; 45 compact participants incl. DC; 13 Medicaid programs covering

Nothing is scored, ranked or recommended. A field we could not verify from a primary source says so instead of guessing.

Assumptions, checked September 4, 2026
  • Licence-lookup addresses were requested from a server with a desktop browser user agent; a 200 (or 202 for single-page apps) is recorded as checked, and a 403, 405, 503 or bot wall as browser-only.
  • Telehealth entries describe non-controlled drugs only and the in-person exam question only. Standard-of-care, consent, record-keeping and audio-only rules are in the cited text and are not summarised here.
  • Medicaid entries describe fee-for-service coverage of GLP-1s prescribed for obesity. Diabetes coverage is separate. Managed-care plans may differ.
  • IMLC membership means an expedited path to a full licence in that state; it is not a multistate licence and it does not change the state's telehealth rules.
  • The compact site is imlcc.com. The older imlcc.org domain no longer belongs to the Commission and is not linked anywhere on this site.
  • Directory last reviewed 2026-09-04. Individual fields carry their own dates.

This calculator is an arithmetic aid for medication a licensed prescriber has already prescribed. It does not recommend a dose. Confirm any result with your prescriber or pharmacist before use.

Sources

  1. Interstate Medical Licensure Compact Commission: participating states (snapshot stats updated August 6, 2026, information as of July 31, 2026)
  2. KFF: Medicaid Coverage of and Spending on GLP-1s, Figure 1 state map (published January 16, 2026)
  3. FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (shortage resolutions for tirzepatide and semaglutide and what 503A pharmacies may still do)
  4. FDA press release, March 3, 2026: FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s
  5. FDA: Human Drug Compounding (compounded drugs are not FDA approved)
  6. CMS National Plan and Provider Enumeration System: NPI Registry
  7. Federation of State Medical Boards: DocInfo physician profile search

Read before you use it

Guides for this calculator

GLP-1 access in Alabama: telehealth rules, licence lookups and Medicaid coverage

Alabama in one card: where to check a prescriber and a pharmacy licence, compact member, telehealth prescribing rule for non-controlled drugs (allowed with conditions), Medicaid position on anti-obesity GLP-1s (not covered for obesity), and what applies to compounded GLP-1s. Sources and check dates on every line.

Updated September 4, 2026

GLP-1 access in Alaska: telehealth rules, licence lookups and Medicaid coverage

Alaska in one card: where to check a prescriber and a pharmacy licence, compact member, telehealth prescribing rule for non-controlled drugs (allowed with conditions), Medicaid position on anti-obesity GLP-1s (not covered for obesity), and what applies to compounded GLP-1s. Sources and check dates on every line.

Updated September 4, 2026

GLP-1 access in Arizona: telehealth rules, licence lookups and Medicaid coverage

Arizona in one card: where to check a prescriber and a pharmacy licence, compact member, telehealth prescribing rule for non-controlled drugs (no in-person exam required), Medicaid position on anti-obesity GLP-1s (not covered for obesity), and what applies to compounded GLP-1s. Sources and check dates on every line.

Updated September 4, 2026

Where next

Elsewhere in the FormBlends network

Compounding Explained503A, 503B, licences, COAs and the enforcement timeline, in plain English.Choosing a GLP-1 ClinicIn-person, telehealth or hybrid: how to pick, and what to ask.GLP-1 Pricing IndexList prices, self-pay programs and compounded ranges, every figure dated.formblends.comFormBlendsformblends.comFormBlends provider and pharmacy directoryformblends.comRegulatory status of compounded GLP-1s (FormBlends)

Educational, not medical advice. Read the medical disclaimer.